Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Rev Neurol (Paris) ; 177(4): 385-393, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33032799

RESUMEN

OBJECTIVES: Parkinsonism in the elderly presents a major risk factor for recurrent falls (2 and more falls per year), which is associated with increased morbidity. The main objective was to investigate explanatory variables relating to the risk of being recurrent fallers (RF) in persons with parkinsonian gait. METHODS: Seventy-nine among 172 eligible persons were enrolled in this prospective study, the findings of which were analyzed at 12 months. Motor and non-motor features, as well as follow-up interviews to identify falls, loss of ability to walk, fluctuating cognition, traumatic falls, all-cause hospitalizations and deaths were collated and results compared between non RF (zero and one fall per year) and RF. Bayesian model averaging was used to predict the probability of patients being RF from their medical history as well as from cognitive assessment, gait velocity, vision and posture. RESULTS: N=79, 0.58 men, 50% had Parkinson's disease, 14% other neurodegenerative parkinsonian syndrome, 23% vascular parkinsonism and 13% Lewy body disease, 58% were RF. Median age 81.2 years and median MMSE 25/30. A history of falls and of hallucinations, median odds ratio respectively 9.06 (CI 2.34-38.22), 4.21 (CI 1.04-18.67) were associated with the highest odds ratios along with fluctuating cognition and abnormal posture. Two or more falls a year was a relevant threshold to distinguish a population with a high risk of comorbidity. CONCLUSION: The whole history of falls, hallucinations and fluctuating cognition can be considered predictive of recurrent falls in elderly people with parkinsonian gait and provide a tracking tool for patient management.


Asunto(s)
Marcha , Enfermedad de Parkinson , Anciano , Teorema de Bayes , Femenino , Humanos , Masculino , Estudios Prospectivos
2.
Int J Clin Pract ; 70(7): 520-36, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27291143

RESUMEN

BACKGROUND: The ageing process is intrinsically associated with decline in physical endurance, muscle strength and gait ability and balance, which all contribute to functional disability. Regular physical training, and more particularly multicomponent training (MCT), has demonstrated many health benefits. OBJECTIVE: To evaluate the evidence of the health benefits of MCT including endurance training, muscle strengthening, balance exercises, and/or stretching (i.e. flexibility training) and/or coordination training in adults aged 65 years or over. METHODS: A comprehensive, systematic database search for manuscripts was performed in CINAHL Plus, Embase, Medline, PubMed Central, ScienceDirect, Scopus, Sport Discus and Web of Science using key words. For potential inclusion, two reviewers independently assessed all intervention studies published in English language from 1 January 2000 to 30 April 2015. RESULTS: Of 2525 articles initially identified, 27 studies were finally included in this systematic review. They were all divided into five categories according to their main outcome measurements (cardio-respiratory fitness, metabolic outcomes, functional and cognitive functions and quality of life, QoL). These studies reported that MCT has a significant beneficial effect on cardio-respiratory fitness and on metabolic outcomes. Substantial improvement in functional and cognitive performance was also measured and a slighter but positive effect on QoL. CONCLUSION: Overall, this review demonstrates a positive effect of MCT with functional benefits and positive health outcomes for seniors. Based on this evidence, clinicians should encourage all adults aged 65 or over to engage in MCT programmes to favour healthy ageing and keeping older members of our society autonomous and independent.


Asunto(s)
Educación y Entrenamiento Físico , Anciano , Envejecimiento , Humanos , Educación y Entrenamiento Físico/métodos , Aptitud Física , Resultado del Tratamiento
3.
Int J Clin Pract ; 69(10): 1032-49, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25963846

RESUMEN

BACKGROUND: The prevalence of obesity is rapidly increasing in older patients and it is ubiquitous in many developed countries. Obesity is related to various negative health outcomes, making it a major public health target for intervention. PURPOSE: The aim of this study was to explore and summarise the literature that addresses endurance training alone or combined with nutrition interventions to combat obesity in obese patients over age 60. METHODS: We searched online electronic databases up to September 2014 for original observational and intervention studies published between 1995 and 2014 on the relationship between endurance training alone or combined with a diet in obese patients over 60 regarding health outcomes. RESULTS: Twenty-six studies examined interventions aimed specifically at promoting endurance training alone or combined with diet for older obese patients over 60. These studies demonstrated a positive effect of this intervention on the primary prevention of cardiovascular disease, and a significant beneficial effect on the lipid profile. Improvement of body composition and insulin sensitivity, and a reduction in blood pressure were also well established. CONCLUSIONS: Overall, this review demonstrates a positive effect of endurance training alone or combined with diet on health outcomes and metabolic benefits in older adults. Clinicians can now use this evidence to formulate actions to encourage the older obese to profit from the health benefits of endurance training and diet. This will not only help reduce the dramatic increase in the number of older obese but also help prevent sarcopenic obesity, which is a complex challenge for healthcare professionals.


Asunto(s)
Dieta , Terapia por Ejercicio/métodos , Estado de Salud , Obesidad/dietoterapia , Obesidad/rehabilitación , Resistencia Física/fisiología , Humanos , Persona de Mediana Edad
4.
Int J Clin Pract ; 67(5): 420-6, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23574102

RESUMEN

AIMS OF THE STUDY: Stiffening of large arteries has been associated with increased cardiovascular outcomes among older subjects. Endurance exercises might attenuate artery stiffness, but little is known about the effects of intermittent training programme. We evaluate the effect of a short Intermittent Work Exercise Training Program (IWEP) on arterial stiffness estimated by the measure of the pulse wave velocity (PWV). METHODS AND SUBJECTS: Seventy-one healthy volunteers (mean age: 64.6 years) free of symptomatic cardiac and pulmonary disease performed a 9-week IWEP that consisted of a 30-min cycling twice a week over a 9-week period. Each session involved six 5-min bouts of exercise, each of the latter separated into 4-min cycling at the first ventilatory threshold alternated with 1-min cycling at 90% of the pretraining maximal tolerated power. Before and after the IWEP, the following measurements were made: carotid-radial PWV and carotid-femoral PWV with a tonometer and systolic and diastolic blood pressure. RESULTS: Training resulted in a non-significant decrease of the carotid-radial PWV, a significant decrease of the carotid-femoral PWV from 10.2 to 9.6 m/s (p < 0.001) (that was no longer significant after adjustment for mean arterial pressure) and a significant decrease in both systolic and diastolic blood pressure, respectively, from 129.6 ± 14.9 mmHg to 120.1 ± 14.1 mmHg (p < 0.001) and from 77.2 ± 8.8 mmHg to 71.4 ± 10.1 mmHg (p < 0.001). CONCLUSION: The present results support the idea that a short-term intermittent aerobic exercise programme may be an effective lifestyle intervention for reducing rapidly blood pressure and probably central arterial stiffness among older healthy subjects.


Asunto(s)
Presión Arterial/fisiología , Ejercicio Físico/fisiología , Anciano , Velocidad del Flujo Sanguíneo/fisiología , Arterias Carótidas/fisiología , Prueba de Esfuerzo , Tolerancia al Ejercicio/fisiología , Femenino , Arteria Femoral/fisiología , Humanos , Masculino , Consumo de Oxígeno/fisiología , Estudios Prospectivos , Análisis de la Onda del Pulso , Pruebas de Función Respiratoria
5.
Rev Neurol (Paris) ; 166(6-7): 653-6, 2010.
Artículo en Francés | MEDLINE | ID: mdl-20219224

RESUMEN

INTRODUCTION: Cognitive disorders such as deficit of attention and executive and visuoconstructive dysfunctions occur in Parkinson's disease dementia (PDD). Memory impairment is not an early feature and statement not well delimited. CASE REPORT: A 78-year-old man with PDD underwent neuropsychological assessment and moreover demonstrated memory decline. After death, pathology examination of the brain and immunohistochemy analysis confirmed PD and showed Lewy body pathology (LBP) in the insula, limbic and especially in CA3 hippocampus areas. Hippocampus and gyrus parahippocampic also exhibited neurofibrillary tangles. Lack of senile plaque and lack of beta A4 amyloid deposition were noticeable in the whole brain examination. CONCLUSION: Severe executive dysfunctions are probably related to LBP and dysfunction in memory process may be related to DNF lesions in medial temporal area.


Asunto(s)
Demencia/patología , Enfermedad de Parkinson/patología , Anciano , Encéfalo/patología , Demencia/etiología , Progresión de la Enfermedad , Humanos , Cuerpos de Lewy/ultraestructura , Masculino , Neuritas/química , Ovillos Neurofibrilares/química , Pruebas Neuropsicológicas , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/psicología , Síndrome de las Piernas Inquietas/complicaciones , Síndrome de las Piernas Inquietas/patología , alfa-Sinucleína/análisis , Proteínas tau/análisis
6.
Int J Clin Pract ; 63(7): 1061-7, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19570123

RESUMEN

Elevated serum homocysteine, decreased folate and low vitamin B(12) serum levels are associated with poor cognitive function, cognitive decline and dementia. Despite evidence of an epidemiological association, randomised controlled trials did not provide any clear evidence so far that supplementation with vitamin B(12) and/or folate improves dementia or slows cognitive decline, even though it might normalise homocysteine levels. In this report, we review the current knowledge on the relationship between homocysteine, folate and vitamin B(12) levels and the way their disruption influences cognitive function in adults.


Asunto(s)
Trastornos del Conocimiento/etiología , Ácido Fólico/metabolismo , Homocisteína/metabolismo , Vitamina B 12/metabolismo , Adulto , Ensayos Clínicos como Asunto , Trastornos del Conocimiento/sangre , Estudios Transversales , Suplementos Dietéticos , Humanos , Estudios Longitudinales , Deficiencia de Vitamina B 12/dietoterapia , Complejo Vitamínico B/administración & dosificación
7.
Int J Clin Pract ; 63(2): 303-20, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19196369

RESUMEN

As the number of elderly persons in our country increases, more attention is being given to geriatric healthcare needs and successful ageing is becoming an important topic in medical literature. Concept of successful ageing is in first line on a preventive approach of care for older people. Promotion of regular physical activity is one of the main non-pharmaceutical measures proposed to older subjects as low rate of physical activity is frequently noticed in this age group. Moderate but regular physical activity is associated with a reduction in total mortality among older people, a positive effect on primary prevention of coronary heart disease and a significant benefit on the lipid profile. Improving body composition with a reduction in fat mass, reducing blood pressure and prevention of stroke, as well as type 2 diabetes, are also well established. Prevention of some cancers (especially that of breast and colon), increasing bone density and prevention of falls are also reported. Moreover, some longitudinal studies suggest that physical activity is linked to a reduced risk of developing dementia and Alzheimer's disease in particular.


Asunto(s)
Ejercicio Físico/fisiología , Aptitud Física/fisiología , Accidentes por Caídas/prevención & control , Anciano , Anciano de 80 o más Años , Composición Corporal , Densidad Ósea/fisiología , Enfermedades Cardiovasculares/prevención & control , Enfermedad Coronaria/prevención & control , Demencia/prevención & control , Diabetes Mellitus Tipo 2/prevención & control , Terapia por Ejercicio , Fracturas Óseas/prevención & control , Humanos , Hipertensión/prevención & control , Lípidos/sangre , Persona de Mediana Edad , Neoplasias/prevención & control , Enfermedades Respiratorias/prevención & control , Caminata/fisiología
8.
Int J Clin Pract ; 63(10): 1472-8, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19769704

RESUMEN

BACKGROUND: Ageing is known to be associated with a decrease in peak oxygen consumption (VO2peak) and maximal tolerated power (MTP). Regular physical exercise is the most appropriate to improve aerobic capacity, but its effect still remained discussed in old people. DESIGN: The aim of this study was to determine whether a short interval training session would be associated with improvements in exercise efficiency in aged subjects in both genders. METHODS: In all, 19 women and 16 men (65.4 +/- 4.9 years) performed a cycle incremental exercise test before and after a 9-week period of aerobic interval training (twice a week, 30 min session where 6 x 4-min at the first ventilatory threshold alternated with 1-min at the second ventilatory threshold) with cycle ergometer. Minute ventilation (MV), O(2) uptake (VO(2)) and CO(2) output (VCO(2)) were measured breath-by-breath and by an open-circuit metabolic cart. RESULTS: Before training, maximal values of MV (MMV), VO2peak, heart rate, systolic blood pressure, MTP, blood lactate at MTP recovery and the power at the first (pVT(1)) and second ventilatory thresholds (pVT(2)) were higher in men compared with women. Nine weeks of interval training induced a significant increase in MMV, VO2peak, MTP, pVT(1) and pVT(2) and decrease in systolic blood pressure in the same way in men than in women, without any significant effect on their maximal heart rate values. CONCLUSIONS: These findings suggest that the age-related declines in aerobic index are attenuated by a short exercise interval training sessions in women and men.


Asunto(s)
Ejercicio Físico/fisiología , Conducta Sedentaria , Anciano , Antropometría , Presión Sanguínea/fisiología , Prueba de Esfuerzo , Femenino , Frecuencia Cardíaca/fisiología , Humanos , Lactatos/sangre , Masculino , Consumo de Oxígeno/fisiología
10.
J Nutr Health Aging ; 10(1): 3-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16453051

RESUMEN

OBJECTIVES: The aim of this trial was to demonstrate the efficacy of one month of oral cobalamin (vitamin B12) therapy in elderly patients with cobalamin deficiency related to food-cobalamin malabsorption (FCM). PATIENTS AND METHOD: Twenty elderly patients (mean age: 78+/-17 years) with established cobalamin deficiency related to FCM were included in an open-label, non-randomized, non-placebo trial. They were treated with a maximum of 1,000 microgram per day of oral crystalline cyanocobalamin for at least 1 month. Serum cobalamin levels (primary endpoint), blood count abnormalities and reticulocytes count (secondary endpoints) were determined at baseline and during the first month of treatment. RESULTS: 85% of the patients normalized their serum cobalamin levels with a mean increase of+167 pg/ml (p<0.001 compared with baseline). 100% of the patients corrected their initial macrocytosis and 25% their anemia; 100% of the patients had medullar regeneration with a mean increase of reticulocytes count of 32+/-11.3 x 106/l (p=0.03 compared with baseline). CONCLUSIONS: Our findings support the view that one month of oral crystalline cyanocobalamin is effective to correct serum vitamin B12 levels and to obtain hematological responses in elderly patients with cobalamin deficiency related to FCM.


Asunto(s)
Síndromes de Malabsorción/complicaciones , Deficiencia de Vitamina B 12/tratamiento farmacológico , Vitamina B 12/sangre , Vitamina B 12/uso terapéutico , Administración Oral , Anciano , Envejecimiento/fisiología , Recuento de Células Sanguíneas , Femenino , Hemoglobinas/análisis , Humanos , Absorción Intestinal , Síndromes de Malabsorción/tratamiento farmacológico , Masculino , Resultado del Tratamiento , Vitamina B 12/administración & dosificación , Deficiencia de Vitamina B 12/etiología
11.
Med Mal Infect ; 36(5): 280-4, 2006 May.
Artículo en Francés | MEDLINE | ID: mdl-16644164

RESUMEN

OBJECTIVE: The authors had for aim to assess, the incidence of symptomatic bacteriuria and the level of antibiotic resistance in bacteria identified in long-term care facilities (LTC). DESIGN: Symptomatic bacteriuria cases were prospectively collected, during 9 months in the two LTC of the Strasbourg French Teaching Hospital (196 beds). RESULTS: One hundred and eleven bacteriuria cases were included. They concerned 67 of the 274 residents (cumulative incidence: 2.07/1,000 patients-day). A gram-negative bacillus was identified in 85% of the symptomatic bacteriuria cases, and Escherichia coli in 40%. Sixty percent of the identified bacterial strain was resistant to amoxicillin (Amx-R) and 42% to the clavulanic acid combination (AmC-R). Third generation cephalosporins (3GC) were effective in 90% of Urinary tract infections (UTIs) and fluoroquinolones in 65% (Fq). Four bacterias with broad beta-lactamase spectrum were identified (0.04%) including 3 Enterobacter aerogenes. No yeast infection was diagnosed. E. coli strains were 65% Amx-R and 50% AmC-R. Concerning the Fq-R strains (15%), 50% were cotrimoxazole resistant (Stx-R) and 70% Amx-R; 3GC remained effective (82%). CONCLUSION: In LTC, multi-drug resistance bacteria are rare and 3GCs seem to be the best first line treatment. Nevertheless, Fq-R is increasing (15 vs 8%), and attention must be paid to the antibiotic therapy used.


Asunto(s)
Bacteriuria/epidemiología , Hospitales de Enseñanza/normas , Cuidados a Largo Plazo/normas , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Bacteriuria/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Francia/epidemiología , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/epidemiología , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/epidemiología , Humanos , Incidencia , Masculino
12.
Rev Med Interne ; 26(12): 938-46, 2005 Dec.
Artículo en Francés | MEDLINE | ID: mdl-15951065

RESUMEN

PURPOSE: Update of the adult cobalamin deficiencies. CURRENT KNOWLEDGE AND KEY POINTS: More precise definitions establish the true cobalamin deficiencies and determine their real epidemiology. The current clinical data suggest the concept of food-cobalamin malabsorption as the leading etiology of cobalamin deficiency. The new features of cobalamin deficiency include neurological, gynecological and vascular manifestations. Current treatment modalities include nasal, sublingual and oral cobalamin administration. PROSPECTS AND PROJECTS: Studies are in the way to establish the relevance of the new clinical manifestations and to validate the usefulness of oral cobalamin therapy.


Asunto(s)
Síndromes de Malabsorción/fisiopatología , Deficiencia de Vitamina B 12/tratamiento farmacológico , Deficiencia de Vitamina B 12/etiología , Vitamina B 12/uso terapéutico , Diagnóstico Diferencial , Dieta , Humanos , Incidencia , Vitamina B 12/farmacocinética , Deficiencia de Vitamina B 12/terapia
13.
Presse Med ; 34(5): 358-62, 2005 Mar 12.
Artículo en Francés | MEDLINE | ID: mdl-15859569

RESUMEN

OBJECTIVE: Non-dissociation of vitamin B12 from its carrying proteins is the most frequent cause of vitamin B12 deficiency in the elderly. The aim of this study was to determine the initial dose of oral cyanocobalamin that would correct the B12 vitamin deficiency within one week. METHODS: This was an open, prospective, study on 30 elderly patients suffering from vitamin deficiency (B12 < 0.20 microg/L) induced by food-cobalamin malabsorption. Ten patients (group I) were treated with a daily dose of 1000 microg of oral cyanocobalamin (from D1 to D8), 10 (group II) with 1000 microg every other day (D1, D3, D5 and D7), 5 (group III) with 1000 microg every 4 days (D1 and D5) and 5 (group IV) with 1000 microg only on D1. The biological response was assessed by control measurement of vitamin B12 serum levels on the 8th day. RESULTS: Mean vitamin B12 serum levels had significantly increased (p < 0.01) in groups I, II and III, but not in group IV. The dose-effect, assessed by the mean increase in vitamin B12 serum levels, was significantly greater (p < 0.05) in groups I (0.25 microg/L) and II (0.18 microg/L), than in groups III and IV (0.09 microg/L). CONCLUSION: This prospective study shows that an oral dose of 1000 microg of cyanocobalamin every 4 days, which corresponds to 250 microg per day, was sufficient to correct B12 vitamin deficiency induced by food-cobalamin malabsorption within one week. However, initial doses of 1000 microg per day or every other day would be preferable because of the greater dose-effect with daily doses higher than 500 microg. A randomised study is warranted to validate these preliminary results.


Asunto(s)
Deficiencia de Vitamina B 12/tratamiento farmacológico , Vitamina B 12/uso terapéutico , Administración Oral , Anciano , Anciano de 80 o más Años , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Humanos , Masculino , Estudios Prospectivos , Resultado del Tratamiento , Vitamina B 12/sangre
14.
Rev Med Interne ; 36(12): 840-2, 2015 Dec.
Artículo en Francés | MEDLINE | ID: mdl-26526776

RESUMEN

The growing use of direct oral anticoagulants, in particular among older subjects, raises questions about the limits of the evidence-based medicine. The phase III studies that have validated the efficacy and the safety profile of these molecules (dabigatran, rivaroxaban, apixaban, edoxaban) in their both indications, the venous thromboembolic disease and the non-valvular atrial fibrillation raise concerns in four major fields: the financial support of pharmaceutical companies, the links of interest for many authors with the industry, the study design (exclusively non-inferiority studies), and the poor representativeness of the older subjects included. All these points are discussed, using data of sub-groups studies, post-marketing studies and recent meta-analysis. The lack of data for the very old subjects, with frailty or comorbidities, remains the main concern from these phase III studies.


Asunto(s)
Anticoagulantes/administración & dosificación , Administración Oral , Factores de Edad , Anciano , Ensayos Clínicos como Asunto , Interpretación Estadística de Datos , Medicina Basada en la Evidencia , Humanos
15.
Rev Med Interne ; 36(1): 22-30, 2015 Jan.
Artículo en Francés | MEDLINE | ID: mdl-25234463

RESUMEN

Prescribing anticoagulant therapy when the CHA2DS2-VASc score is ≥ 1 prevents strokes secondary to non-valvular atrial fibrillation (AF). However, it is important to remember that whether the aged population has the highest risk of stroke in case of AF, under anticoagulant therapy this population is also at the highest risk of bleeding. Vitamin K antagonists were for decades the molecules of reference with benefits even after 75 years of age. The direct oral anticoagulants have overcome the biological constraints inherent to monitoring vitamin K antagonists and provide a more stable pharmacological action with a limited number of drug-drug interactions. However, the widespread use of these molecules in the older population remains controversial. In this review article, indications and modalities of administration of anticoagulant therapy in the elderly will be detailed and discussed on the basis of the most recent recommendations proposed in particular by the European Society of Cardiology. Particular attention will be paid to new oral anticoagulant therapies compared with vitamin K antagonists and antiplatelet agents.


Asunto(s)
Anticoagulantes/administración & dosificación , Fibrilación Atrial/tratamiento farmacológico , Administración Oral , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/complicaciones , Fibrilación Atrial/diagnóstico , Actitud del Personal de Salud , Evaluación Geriátrica , Humanos , Médicos , Factores de Riesgo , Accidente Cerebrovascular/diagnóstico , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/prevención & control
16.
Ann Clin Biochem ; 32 ( Pt 3): 314-24, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7632037

RESUMEN

We performed a methodological comparison of free triiodothyronine (FT3) estimates in patients with liver cirrhosis and renal failure. Patients were classified in terms of severity of illness on the basis of their total triiodothyronine, total thyroxine and reverse triiodothyronine profiles. FT3 levels, measured in direct dialysis, microchromatography, labelled analogue and two-step immunoextraction assays were significantly (P < 0.01) lower than the control group in all patient categories. However, FT3 measured by a labelled antibody radioimmunoassay was significantly reduced only in the most severely ill sub-group of patients. In a further group of patients on long-term amiodarone therapy for cardiac disease all FT3 methods, with the exception of the labelled antibody radioimmunoassay and an analogue method, yielded significantly (P < 0.01) reduced levels. A significant negative association between FT3 and subject age was demonstrated for all methods except the labelled antibody radioimmunoassay, and a weak but significant negative correlation between log thyrotropin and FT3 was only seen with this assay. Three methods demonstrated a correlation (P < 0.02) with albumin levels in patients with the 'low T3 syndrome'. In this group, albumin had a predictive value (P < or = 0.02) for four out of six assays as determined by stepwise variable selection. Our findings suggest that users of FT3 assays should exercise caution in interpreting results in non-thyroidal illness and amiodarone treated patients, as there are method-related differences in the profiles obtained.


Asunto(s)
Inmunoensayo/métodos , Cirrosis Hepática/metabolismo , Insuficiencia Renal/metabolismo , Triyodotironina/sangre , Adulto , Anciano , Amiodarona/uso terapéutico , Humanos , Cirrosis Hepática/tratamiento farmacológico , Persona de Mediana Edad , Insuficiencia Renal/tratamiento farmacológico , Sensibilidad y Especificidad
17.
Rev Med Interne ; 25(1): 46-53, 2004 Jan.
Artículo en Francés | MEDLINE | ID: mdl-14736560

RESUMEN

PURPOSE: Most of the antibiotic-associated diarrhea (AAD) cases result from a transient disturbance in the function of the normal intestinal flora and are spontaneously solved when discontinuing the antibacterial therapy. However, a mild diarrhea lasting several days may induce a dehydration or worsen a denutrition in frail elderly people. CURRENT KNOWLEDGE AND KEY POINTS: The incidence of AAD varies between 5 and 25% depending on the concerned antibiotic. Only 10-20% of all AAD cases are caused by infection, especially with Clostridium difficile, for which advanced age is a major risk factor. The first biological exam to perform when severe AAD or in frail people is the detection of C. difficile toxins, especially in elderly patient treated with beta-lactam antibiotics. Nevertheless, other infectious organisms causing AAD may be considered, as Staphylococcus aureus when predominant in stool cultures from patients treated with fluoroquinolones or as Klebsiella oxytoca when isolated in bloody diarrhea from patients treated with ampicillin. Elevated fecal counts of Candida spp. found in patients treated with antibiotics is rather the consequence of therapy than the cause of AAD. The prevention of AAD is based on a rational antibiotic use to avoid endogenous selection of C. difficile and on the improvement of the hygiene measures to limit the exogenous transmission of the bacteria or related spores by spoiled hands. FUTURE PROSPECTS: Simultaneous prescription of non-pathogenic living organisms, capable of re-establishing the equilibrium of the intestinal flora, should be better described, especially in elderly people, because of its important economic impact.


Asunto(s)
Antibacterianos/efectos adversos , Diarrea/inducido químicamente , Factores de Edad , Anciano , Árboles de Decisión , Diarrea/epidemiología , Diarrea/microbiología , Diarrea/fisiopatología , Diarrea/prevención & control , Humanos , Factores de Riesgo
18.
Rev Med Interne ; 14(10): 964, 1993.
Artículo en Francés | MEDLINE | ID: mdl-8009060

RESUMEN

To evaluate the influence of blood transfusion on the serum levels of different nutrients, the levels of total iron binding capacity, ferritin, cobalamin and folate were determined before and 24 hours after 2 or 3 packed red cell transfusions, by forty patients with anemia of various causes. No significant change was found in these levels before and after blood transfusion, except for iron and folate.


Asunto(s)
Anemia/sangre , Transfusión Sanguínea , Adulto , Anciano , Anciano de 80 o más Años , Anemia/terapia , Femenino , Ferritinas/sangre , Ácido Fólico/sangre , Humanos , Masculino , Persona de Mediana Edad , Transferrina/inmunología , Vitamina B 12/sangre
19.
Rev Med Interne ; 17(2): 145-9, 1996.
Artículo en Francés | MEDLINE | ID: mdl-8787086

RESUMEN

POEMS syndrome is a systemic disorder with peripheral neuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes. The association of POEMS syndrome with lympho-proliferative disorder is very commun. The pathogenesis remains poorly understood but implication of cytokines (interleukins 1 and 6) is suspected. We report a case of a classic POEMS syndrome (with polyneuropathy, hepatomegaly, diabetes melitus, hyperpigmentation, monoclonal IgG lambda, anasarca and solitary plasmocytoma), associated with high serum levels of interleukin 6.


Asunto(s)
Interleucina-6/fisiología , Síndrome POEMS/fisiopatología , Humanos , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Síndrome POEMS/sangre , Síndrome POEMS/diagnóstico , Pronóstico
20.
Rev Med Interne ; 23(3): 328-31, 2002 Mar.
Artículo en Francés | MEDLINE | ID: mdl-11928382

RESUMEN

INTRODUCTION: Candidemia, principally affecting neutropenic patients in departments of oncohematology and frail patients in intensive care units, can also be observed in frail elderly people in geriatrics. EXEGESIS: Authors report four observations of candidemia diagnosed in elderly dependent patients having several different diseases. Clinical sign was a persistent or recurrent fever after a wide-spectrum antibiotic therapy. Patients were treated by fluconazole leading to negative blood cultures in several days. Three out of four patients died within the weeks following antifungal therapy due to severity of associated diseases. CONCLUSION: These observations show that a diagnosis of candidemia should be made when a persistent fever is observed in a frail elderly person. Fluconazole, as efficient as amphotericin B and well tolerated by elderly people, should be the first treatment of candidemia in non-neutropenic patients.


Asunto(s)
Candidiasis , Fungemia , Anciano , Anciano de 80 o más Años , Antifúngicos/administración & dosificación , Antifúngicos/uso terapéutico , Candida/aislamiento & purificación , Candidiasis/diagnóstico , Candidiasis/tratamiento farmacológico , Candidiasis/etiología , Femenino , Fluconazol/administración & dosificación , Fluconazol/uso terapéutico , Anciano Frágil , Fungemia/diagnóstico , Fungemia/tratamiento farmacológico , Fungemia/etiología , Humanos , Masculino , Recurrencia , Factores de Riesgo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA